Patients with Chronic Lymphocytic Leukemia Carrying t(14;19) Display a Distinctive Transcriptomic Profile and Adverse Outcome, Which Might be Overcome Continuous Therapy with BTK Inhibitors. an Italian Campus CLL and Eric Study
- Resource Type
- Article
- Source
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p3275-3275, 1p
- Subject
- Language
- ISSN
- 00064971; 15280020